rituximab (Rituxan) to be used in combination with methotrexate for rheumatoid arthritis
August 2006
Health Canada now approves rituximab (Rituxan) to be used in combination with methotrexate for rheumatoid arthritis.
Rheumatoid arthritis affects 1 out of every 100 Canadians.
Researchers believe cells that produce antibodies play a key role in the inflammation and progression of rheumatoid arthritis. These are B-cells. Rituximab selectively targets B-cells...allowing the immune system to recognize and eliminate them.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote